The Australian Survey of High Impact Psychoses (SHIP) reported on a representative sample of 1825 people with schizophrenia and related disorders, and collected extensive information about their lives, their symptoms, their health status, and also their service utilisation and unmet needs. 2 For the purposes of this editorial, we consider the subjective reports of the SHIP study participants in response to the open question: 'What are the three most important challenges you will face in the coming year?' These were, in rank order: financial problems (endorsed by 42.7% of participants); loneliness and social isolation (37.2%); unemployment (35.1%); physical health concerns (27.4%); and uncontrolled symptoms of mental illness (25.7%).
T his issue of Australasian Psychiatry contains a number of important articles addressing the treatment and recovery of people with schizophrenia. This is timely considering the recent publication of the Royal Australian and New Zealand College of Psychiatrists (RANZCP) Clinical Practice Guideline for Schizophrenia and Related Disorders. 1 The Australian Survey of High Impact Psychoses (SHIP) reported on a representative sample of 1825 people with schizophrenia and related disorders, and collected extensive information about their lives, their symptoms, their health status, and also their service utilisation and unmet needs. 2 For the purposes of this editorial, we consider the subjective reports of the SHIP study participants in response to the open question: 'What are the three most important challenges you will face in the coming year?' These were, in rank order: financial problems (endorsed by 42.7% of participants); loneliness and social isolation (37.2%); unemployment (35.1%); physical health concerns (27.4%); and uncontrolled symptoms of mental illness (25.7%).
What we see, then, is that people with schizophrenia have a desire for integration into the community, to live meaningful lives, and to be productive members of society. They are also concerned about ongoing mental health symptoms and about their physical health. This holistic set of aspirations is fully compatible with the Recovery concept, which is underpinning much of modern psychiatric practice. 3 Work is highlighted as an aspiration by many people with schizophrenia and related disorders, but, regrettably, we are failing to achieve work participation for many such individuals. The SHIP study found only around 20% of respondents were in full-or part-time paid employment, and this figure had not changed from the previous Australian Psychosis Survey conducted in 1997/8. 4 The review by Modini in this issue points out the mental health benefits of work. Work gives people structure, meaning, social opportunities, and also provides income. We must see assisting people with schizophrenia to obtain and retain work as an integral part of service delivery. To achieve this, we need models which are relevant to our local settings. In this issue, we present a pilot study using the Optimal Health Framework 5 adapted specifically to assist people with mental illness to obtain and retain work. Whilst very preliminary and requiring proper exploration in a randomised controlled trial, our findings were encouraging in terms of the number of people who either achieved work or commenced studies or engaged in volunteering: study and volunteering are very helpful first steps for a return to paid work, and can aid socialisation, self-confidence, and structured use of time. We also know that cognitive remediation can assist people with schizophrenia enhance certain aspects of cognition, and this is particularly helpful for people attempting work. In this issue, Newman provides practical guidance about how cognitive remediation can be implemented in 'real life' mental health settings.
The physical health of people with schizophrenia and related disorders has been high on the agenda of our own College (the RANZCP) and the poor physical health of many people with schizophrenia was highlighted starkly by the SHIP study. 6 This highlights the potential role of exercise physiologists in mental health and the importance of the consensus statement published in this issue. A paper from Japan by Hashimoto et al. underlines the benefits of educating patients about their medication. We usually assume that we educate our patients, but need constantly to ensure we are providing full and balanced information and to recognise that patients may acknowledge a need for medication alongside dissatisfaction with taking it, with its effectiveness, or with its unwanted effects. 7 We also need to be aware of the extent to which patients (and carers) obtain information from the internet; and in New Zealand there is the added problem, as in the US, that the pharmaceutical industry can advertise directly to Taken together then, these articles should encourage us to ensure we elicit and explore the aspirations and goals of people with schizophrenia, provide comprehensive information about their treatment and recovery options, and foster shared decision-making consistent with recovery-informed practice. Psychiatrists will continue to be experts in evidence-based prescribing but must support and participate in more widespread delivery of psychosocial interventions in mental health settings. 
Clinical management of ultra-rapid metabolism of antidepressant medication
In the August 2016 issue of the Australasian Psychiatry podcast, Dr Andrew Amos speaks with Professor Gordon Parker about his article on the clinical management of patients who are ultra-rapid metabolisers of antidepressant medications. Professor Parker starts with the premise that much of the heterogeneity of response to antidepressant medication is due to the poor reliability of diagnosis, and proposes that antidepressant medication is particularly indicated for patients with melancholic forms of depression. Professor Parker suggests we should be sensitive to the possibility of ultra-rapid metabolism in patients with melancholic depression who report no clinical benefit and no side effects of medication at higher doses, including in young patients experiencing their first episode. He describes his approach, which includes the use of tricyclic antidepressants both because of the existence of serum level assays, and for their greater efficacy in some patients with depression. Finally, Professor Parker discusses the use of stimulant medications and ketamine in patients with treatment-resistant depression, and issues a challenge to the profession to improve the evidence base for treatment-resistant depression and ultra-rapid metabolisers in particular.
Cover art
The cover art by Renee Sutton comes from the Cunningham Dax Collection. The artwork has been chosen to reflect the theme of recovery in schizophrenia. About this artwork: Renée reconnects to her memory of a close male companion that she was in love with. He told her that she laughed too much, which incidentally, led her to continue to laugh. She visualises herself laughing, as the kookaburra.
Over a number of years Renee Sutton was in and out of hospital, however she continued to practise as a nurse during periods that she was well. In 1991 she retired, and subsequently began attending Artbeat at the Sandy Beach Centre, Melbourne, an art group for elderly patients through which new artistic techniques and ideas about art are shared, and which a sense of community was established. Renée Sutton passed away on November 3, 2015.
About the Cunningham Dax Collection
The Cunningham Dax Collection consists of over 15,000 artworks created by people with an experience of mental illness and/or psychological trauma. The art includes works on paper, paintings, photographs, poems, textiles, sculpture, journals and digital media. The unique Cunningham Dax Collection is now one of the largest of its kind, with only two other similar collections of comparable size and stature: the Musée Art Brut in Lausanne, Switzerland, and the Prinzhorn Collection in Heidelberg, Germany.
The Dax Centre is a not-for-profit organisation that relies on the generosity of the community to carry out its mission of promoting mental health through art. We aim to change community attitudes to mental illness by increasing empathy and understanding of mental illness, psychological trauma and the mind through art, thereby reducing stigma against mentally ill people. The Dax Centre holds an important history and clinical focus, but it is today visited by many people such as students from a diverse range of learning purposes, artists and those interested in art, community and special interest groups; all who seek to demystify mental illness and address the associated stigma that has historically underpinned individual and community perceptions of mentally ill and traumatised persons.
For more information on the Cunningham Dax Collection and The Dax Centre, visit: www.daxcentre.org
